2024-03-29T08:05:24Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_9DCEB3C7D983
2024-03-23T02:45:17Z
openaire
documents
urnserval
serval:BIB_9DCEB3C7D983
Short fluorodeoxyuridine exposure of different human glioblastoma lines induces high-level accumulation of S-phase cells that avidly incorporate 125I-iododeoxyuridine.
10.1007/s00259-005-0009-y
000237324100016
16450135
Perillo-Adamer
F.
author
Delaloye
A.B.
author
Genton
C.S.
author
Schaffland
A.O.
author
Dupertuis
Y.M.
author
Buchegger
F.
author
article
casereport
2006-05
European Journal of Nuclear Medicine and Molecular Imaging
1619-7070
journal
33
5
613-620
Cell Cycle/drug effects
Cell Cycle/radiation effects
Cell Line, Tumor
Dose-Response Relationship, Drug
Floxuridine/administration & dosage
Glioblastoma/metabolism
Glioblastoma/pathology
Humans
Idoxuridine/pharmacokinetics
Iodine Radioisotopes/pharmacokinetics
Metabolic Clearance Rate/drug effects
Radiopharmaceuticals/pharmacokinetics
eng
60_published
true
peer-reviewed
Publication types: Comparative Study ; Journal Article. - Old month value: May
https://serval.unil.ch/notice/serval:BIB_9DCEB3C7D983
https://serval.unil.ch/resource/serval:BIB_9DCEB3C7D983.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_9DCEB3C7D9832
Copying allowed only for non-profit organizations